Literature DB >> 12743268

Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.

Tuofu Zhu1, Lawrence Corey, Yon Hwangbo, Jean M Lee, Gerald H Learn, James I Mullins, M Juliana McElrath.   

Abstract

Some individuals remain inexplicably seronegative and lack evidence for human immunodeficiency virus type 1 (HIV-1) infection by conventional serologic or virologic testing despite repeated high-risk virus exposures. Here, we examined 10 exposed seronegative (ES) individuals exhibiting HIV-1-specific cytotoxicity for the presence of HIV-1. We discovered HIV-1 DNA in resting CD4(+) T cells (mean, 0.05 +/- 0.01 copies per million cells) at multiple visits spanning 69 to 130 weeks in two ES individuals at levels that were on average 10(4)- to 10(6)-fold lower than those of other HIV-1-infected populations reported. Sequences of HIV-1 envelope and gag genes remained markedly homogeneous, indicating little to undetectable virus replication. These results provide the evidence for HIV-1 infection in ES individuals below the detection limit of standard assays, suggesting that extraordinary control of infection can occur. The two HIV-infected ES individuals remained healthy and were not superinfected with other HIV-1 strains despite continued high-risk sexual exposures to multiple HIV-infected partners. Understanding the mechanisms that confer diminished replicative capacity of HIV-1 in these hosts is paramount to developing strategies for protection against and control of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743268      PMCID: PMC154986          DOI: 10.1128/jvi.77.11.6108-6116.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Immune control of HIV-1 after early treatment of acute infection.

Authors:  E S Rosenberg; M Altfeld; S H Poon; M N Phillips; B M Wilkes; R L Eldridge; G K Robbins; R T D'Aquila; P J Goulder; B D Walker
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

4.  Genetic evaluation of suspected cases of transient HIV-1 infection of infants.

Authors:  L M Frenkel; J I Mullins; G H Learn; L Manns-Arcuino; B L Herring; M L Kalish; R W Steketee; D M Thea; J E Nichols; S L Liu; A Harmache; X He; D Muthui; A Madan; L Hood; A T Haase; M Zupancic; K Staskus; S Wolinsky; P Krogstad; J Zhao; I Chen; R Koup; D Ho; B Korber; R J Apple; R W Coombs; S Pahwa; N J Roberts
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

5.  Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS.

Authors:  M M Berrey; T Schacker; A C Collier; T Shea; S J Brodie; D Mayers; R Coombs; J Krieger; T W Chun; A Fauci; S G Self; L Corey
Journal:  J Infect Dis       Date:  2001-04-24       Impact factor: 5.226

6.  Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.

Authors:  R Shankarappa; J B Margolick; S J Gange; A G Rodrigo; D Upchurch; H Farzadegan; P Gupta; C R Rinaldo; G H Learn; X He; X L Huang; J I Mullins
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

8.  Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.

Authors:  K K Van Rompay; M L Marthas; J D Lifson; C J Berardi; G M Vasquez; E Agatep; Z A Dehqanzada; K C Cundy; N Bischofberger; N C Pedersen
Journal:  AIDS Res Hum Retroviruses       Date:  1998-06-10       Impact factor: 2.205

9.  Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.

Authors:  M B McChesney; J R Collins; D Lu; X Lu; J Torten; R L Ashley; M W Cloyd; C J Miller
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  25 in total

1.  Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection.

Authors:  Helen Horton; Colin Havenar-Daughton; Deborah Lee; Erin Moore; Jianhong Cao; John McNevin; Thomas Andrus; Haiying Zhu; Abbe Rubin; Tuofu Zhu; Connie Celum; M Juliana McElrath
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 2.  Current advances in HIV vaccines.

Authors:  M Patricia D'Souza; Mary Allen; Rebecca Sheets; Margaret I Johnston
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

Review 3.  Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.

Authors:  Barbara L Shacklett
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

4.  Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level.

Authors:  A L Erickson; C B Willberg; V McMahan; A Liu; S P Buchbinder; L A Grohskopf; R M Grant; D F Nixon
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

Review 5.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

6.  Monoclonal and Single Domain Antibodies Targeting β-Integrin Subunits Block Sexual Transmission of HIV-1 in In Vitro and In Vivo Model Systems.

Authors:  Janet Tai Guedon; Kun Luo; Hong Zhang; Richard B Markham
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

7.  Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Authors:  Timothée Bruel; Chiraz Hamimi; Nathalie Dereuddre-Bosquet; Antonio Cosma; So Youn Shin; Aurélien Corneau; Pierre Versmisse; Ingrid Karlsson; Benoit Malleret; Brice Targat; Françoise Barré-Sinoussi; Roger Le Grand; Gianfranco Pancino; Asier Sáez-Cirión; Bruno Vaslin
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

8.  Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3.

Authors:  Pushpa Jayaraman; Tuofu Zhu; Lynda Misher; Deepika Mohan; LaRene Kuller; Patricia Polacino; Barbra A Richardson; Helle Bielefeldt-Ohmann; David Anderson; Shiu-Lok Hu; Nancy L Haigwood
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.

Authors:  Jennifer A Fulcher; Yon Hwangbo; Rafael Zioni; David Nickle; Xudong Lin; Laura Heath; James I Mullins; Lawrence Corey; Tuofu Zhu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Authors:  Kristina E Howard; Stacie K Reckling; Erin A Egan; Gregg A Dean
Journal:  Retrovirology       Date:  2010-01-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.